首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 醫療設備 > 導管 > 美國的非血管支架市場:2011年
產業/市場分類
醫療設備 (4528)
內視鏡檢查設備 (158)
分子呈像/呈影劑 (28)
心血管設備 (335)
可拋式醫學設備 (76)
核子醫學 (80)
病患監測 (382)
眼科設備 (102)
傷口護理 (159)
超音波 (54)
齒科設備 (174)
導管 (232)
整形外科 (335)
醫學影像診斷 (414)
體外診斷設備 (476)
CT/MRI/X光 (172)
e保健 (321)
市場調查報告書

美國的非血管支架市場:2011年

US Markets for Nonvascular Stents 2011

出版商 Millennium Research Group
出版日期 2011年06月 商品編碼 203767
內容資訊 英文  
價格
US $ 5995 Web Access and PDF Download (Single user license)
US $ 9000 Web Access and PDF Download (Corporate use license)


美國的非血管支架市場:2011年 是由出版商Millennium Research Group在2011年06月所出版的。 這份英文市場調查報告書價格從美金5995起跳。

簡介

非血管支架，在低侵襲性治療下能緩解疼痛、縮短回復的時間，縮短入院期以降低成本，在這些優勢下，這個需求持續擴大。再者，高齡化讓老人愈來愈普遍，也是造成需要這個支架治療的患者需求增加的一個原因。以大型跨國際企業為首，大大小小不同企業都開始加入這個市場，競爭策略將圍繞在減少患者的併發症等產品改良、或增加使用高價產品上。

本報告提供美國的非血管支架市場概要，以及輸尿管支架，支氣管支架，膽管支架，食道支架，結腸支架，前列腺支架等各別市場概及與競爭分析等資料，為您概述為以下內容。

摘要整理

方法論

第1章 美國的非血管支架市場

  • 市場概要
  • 市場分析
    • 最新趨勢
    • 市場定義
    • 治療
    • 市場預測
    • 推動市場因素和阻礙因素
  • 競爭分析
    • 競爭環境
    • 市場佔有率
    • 競爭企業
      • Boston Scientific
      • Cook Medical
      • C.R. Bard
      • Merit Endotek
      • Olympus/Gyrus-ACMI
      • 其他

第2章 輸尿管支架市場

  • 市場概要
  • 市場分析
    • 市場定義
    • 治療
    • 市場預測
    • 推動市場因素和阻礙因素
  • 競爭分析

第3章 胰臟、肝膽管支架市場

  • 市場概要
  • 市場分析
    • 市場定義
    • 治療
    • 市場預測
    • 推動市場因素和阻礙因素
  • 競爭分析

第4章 食道支架市場

  • 市場概要
  • 市場分析
    • 市場定義
    • 治療
    • 市場預測
    • 推動市場因素和阻礙因素
  • 競爭分析

第5章 結腸、十二指腸和幽門支架市場

  • 市場概要
  • 市場分析
    • 市場定義
    • 治療
    • 市場預測
    • 推動市場因素和阻礙因素
  • 競爭分析

第6章 支氣管·氣管支架市場

  • 市場概要
  • 市場分析
    • 市場定義
    • 治療
    • 市場預測
    • 推動市場因素和阻礙因素
  • 競爭分析

第7章 前列腺支架市場

  • 市場概要
  • 市場分析
    • 市場定義
    • 治療
    • 市場預測
    • 推動市場因素和阻礙因素
  • 競爭分析

附錄

目錄

Abstract

Nonvascular stents - comprising ureteral, biliary and pancreatic, esophageal, colonic and duodenal/pyloric, bronchial and tracheal, and prostatic stents - are used in minimally invasive treatments for a variety of indications. Demand for these devices will be driven by the benefits of minimally invasive treatments, including less pain, faster recovery, and shorter hospital stays (and therefore lower health care costs). In addition, many of the conditions these stents can treat are becoming more common as the elderly - who are more susceptible to these conditions - grow as a proportion of the overall US population. In terms of competitors, a range of companies are active in this space including large multinationals, smaller competitors, and single-product start-ups. Key competitive strategies will center around product improvements, especially to reduce patient complications; increasing the use of premium-priced products, such as self-expanding metal stents; and training more physicians to place nonvascular stents, especially newer types.

Companies mentioned in this report:

  • AbbeyMoor Medical
  • Abbott Vascular
  • American Medical Systems
  • Applied Medical
  • Atrium Medical
  • Boston Medical Products
  • Boston Scientific
  • Bryan Corporation
  • C. R. Bard
  • CONMED
  • Cook Medical
  • Cordis
  • EndoChoice
  • ev3 (acquired by Covidien)
  • Fossa Medical
  • Hobbs Medical
  • Hood Laboratories
  • IDEV Technologies
  • Medinol
  • Medtronic Vascular
  • Merit Endotek (a subsidiary of Merit Medical Systems)
  • M.I.Tech
  • Olympus/Gyrus-ACMI
  • SquareOne
  • Taewoong Medical
  • Teleflex Medical

RESEARCH METHODOLOGY

This report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include

  • Government sources:
    • Securities and Exchange Commission filings
    • Food and Drug Administration and patent filings
    • National Center for Health Statistics data
  • Nonvascular stent companies:
    • Annual reports, product brochures, corporate profiles, etc.
  • Internal databases and reports:
    • Previous reports on similar/related sources
  • General Internet searches, medical literature, and newspaper/magazine searches:
    • Identifying various centers of specialization and articles that might provide leads for primary research

The secondary research stage builds the foundation for the primary research.

The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is either discarded or marked as high- or low-priority and then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various nonvascular stent market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes - unit sales, average selling prices [ASPs], and revenues - as well as market shares).

Step 3: At this stage, the research is in position for its most important primary phase - expert interviews. Throughout the secondary research phase, industry and medical experts are identified. These experts are then contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of each particular interviewee, although in most cases, the most important questions are asked of all experts.

The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then augmented, discarded, or adjusted based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and to reach positions of consensus on issues and market numbers.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

METHODOLOGY

1.0 US NONVASCULAR STENT MARKET

  • 1.1. Market Overview
  • 1.2. Market Analysis
    • 1.2.1. Key Report Updates
    • 1.2.2. Market Definitions
    • 1.2.3. Procedures
    • 1.2.4. Market Forecast
    • 1.2.5. Market Drivers and Limiters
  • 1.3. Competitive Analysis
    • 1.3.1. Competitive Landscape
    • 1.3.2. Market Shares
    • 1.3.3. Competitor Discussions (in Alphabetical Order)
      • Boston Scientific
      • Cook Medical
      • C. R. Bard
      • Merit Endotek (a Subsidiary of Merit Medical Systems)
      • Olympus/Gyrus-ACMI
      • Other

2.0 URETERAL STENT MARKET

  • 2.1. Market Overview
  • 2.2. Market Analysis
    • 2.2.1. Market Definitions
    • 2.2.2. Procedures
    • 2.2.3. Market Forecast
    • 2.2.4. Market Drivers and Limiters
  • 2.3. Competitive Analysis
    • 2.3.1. Competitive Landscape
    • 2.3.2. Market Shares

3.0 BILIARY AND PANCREATIC STENT MARKET

  • 3.1. Market Overview
  • 3.2. Market Analysis
    • 3.2.1. Market Definitions
    • 3.2.2. Procedures
    • 3.2.3. Market Forecast
    • 3.2.4. Market Drivers and Limiters
  • 3.3. Competitive Analysis
    • 3.3.1. Competitive Landscape
    • 3.3.2. Market Shares

4.0 ESOPHAGEAL STENT MARKET

  • 4.1. Market Overview
  • 4.2. Market Analysis
    • 4.2.1. Market Definitions
    • 4.2.2. Procedures
    • 4.2.3. Market Forecast
    • 4.2.4. Market Drivers and Limiters
  • 4.3. Competitive Analysis
    • 4.3.1. Competitive Landscape
    • 4.3.2. Market Shares

5.0 COLONIC AND DUODENAL/PYLORIC STENT MARKET

  • 5.1. Market Overview
  • 5.2. Market Analysis
    • 5.2.1. Market Definitions
    • 5.2.2. Procedures
    • 5.2.3. Market Forecast
    • 5.2.4. Market Drivers and Limiters
  • 5.3. Competitive Analysis
    • 5.3.1. Competitive Landscape
    • 5.3.2. Market Shares

6.0 BRONCHIAL AND TRACHEAL STENT MARKET

  • 6.1. Market Overview
  • 6.2. Market Analysis
    • 6.2.1. Market Definitions
    • 6.2.2. Procedures
    • 6.2.3. Market Forecast
    • 6.2.4. Market Drivers and Limiters
  • 6.3. Competitive Analysis
    • 6.3.1. Competitive Landscape
    • 6.3.2. Market Shares

7.0 PROSTATIC STENT MARKET

  • 7.1. Market Overview
  • 7.2. Market Analysis
    • 7.2.1. Market Definitions
    • 7.2.2. Procedures
    • 7.2.3. Market Forecast
    • 7.2.4. Market Drivers and Limiters
  • 7.3. Competitive Analysis
    • 7.3.1. Competitive Landscape
    • 7.3.2. Market Shares

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL FIGURES

LIST OF FIGURES AND TABLES

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

  • Figure 1: Nonvascular Stent Market, by Material, US (US$), 2009 - 2015
  • Figure 2: Ureteral Stent Market, US (US$), 2009 - 2015
  • Figure 3: Biliary and Pancreatic Stent Procedures, by Technique, US, 2009 - 2015
  • Figure 4: Esophageal Stent Market, by Type, as a % of Total, US, 2009 - 2015
  • Figure 5: Colonic and Duodenal/Pyloric Stent Market Growth, by Type, US, 2010 - 2015
  • Figure 6: Bronchial and Tracheal Stent Market, by Material, US (US$), 2009 - 2015
  • Figure 7: Prostatic Stent Market, by Type, as a % of Total, US, 2010 and 2015
  • Table 1: Companies Mentioned in This Report

METHODOLOGY

1.0 US NONVASCULAR STENT MARKET

  • Figure 8: Nonvascular Stent Market, by Site, US (US$), 2009 - 2015
  • Table 2: Key Report Updates, 2011
  • Table 3: Characteristics of Selected Nonvascular Stent Brands, by Site, US
  • Table 4: Nonvascular Stent Procedures, by Site, US, 2009 - 2015
  • Table 5: Nonvascular Stent Market, by Material, US (US$), 2009 - 2015
  • Table 6: Nonvascular Stent Market, by Site, US (US$), 2009 - 2015
  • Table 7: Drivers of the Nonvascular Stent Market, US
  • Table 8: Limiters of the Nonvascular Stent Market, US
  • Figure 9: Leading Competitors in the Nonvascular Stent Market, as a % of Total, US, 2009 and 2010
  • Table 9: Leading Competitors in the Nonvascular Stent Market, by Material, as a % of Total, US, 2009 and 2010
  • Table 10: Leading Competitors in the Nonvascular Stent Market, by Site, as a % of Total, US, 2009 and 2010

2.0 URETERAL STENT MARKET

  • Figure 10: Ureteral Stent Market, US (US$), 2009 - 2015
  • Table 11: Ureteral Stent Procedures, US, 2009 - 2015
  • Table 12: Ureteral Stent Market, US (US$), 2009 - 2015
  • Table 13: Drivers of the Ureteral Stent Market, US
  • Table 14: Limiters of the Ureteral Stent Market, US
  • Table 15: Leading Competitors in the Ureteral Stent Market, as a % of Total, US, 2010

3.0 BILIARY AND PANCREATIC STENT MARKET

  • Figure 11: Biliary and Pancreatic Stent Market, by Material, US (US$), 2009 - 2015
  • Table 16: Biliary and Pancreatic Stent Procedures, by Technique, US, 2009 - 2015
  • Table 17: Biliary and Pancreatic Stent Market, by Material, US (US$), 2009 - 2015
  • Table 18: Biliary and Pancreatic Stent Market, by Type, US (US$), 2009 - 2015
  • Table 19: Biliary and Pancreatic Stent Market Growth, by Type, US, 2010 - 2015
  • Table 20: Biliary and Pancreatic Stent Market, by Type, as a % of Total, US, 2009 - 2015
  • Table 21: Drivers of the Biliary and Pancreatic Stent Market, US
  • Table 22: Limiters of the Biliary and Pancreatic Stent Market, US
  • Table 23: Leading Competitors in the Biliary and Pancreatic Stent Market, by Material, as a % of Total, US, 2009

4.0 ESOPHAGEAL STENT MARKET

  • Figure 12: Esophageal Stent Market, by Type, US (US$), 2009 - 2015
  • Table 24: Esophageal Stent Procedures, US, 2009 - 2015
  • Table 25: Esophageal Stent Market, by Material, US (US$), 2009 - 2015
  • Table 26: Esophageal Stent Market, by Type, US (US$), 2009 - 2015
  • Table 27: Esophageal Stent Market Growth, by Type, US, 2010 - 2015
  • Table 28: Esophageal Stent Market, by Type, as a % of Total, US, 2009 - 2015
  • Table 29: Drivers of the Esophageal Stent Market, US
  • Table 30: Limiters of the Esophageal Stent Market, US
  • Table 31: Leading Competitors in the Esophageal Stent Market, by Material, as a % of Total, US, 2009

5.0 COLONIC AND DUODENAL/PYLORIC STENT MARKET

  • Figure 13: Colonic and Duodenal/Pyloric Stent Market, by Type, US (US$), 2009 - 2015
  • Table 32: Colonic and Duodenal/Pyloric Stent Procedures, US, 2009 - 2015
  • Table 33: Colonic and Duodenal/Pyloric Stent Market, by Type, US (US$), 2009 - 2015
  • Table 34: Colonic and Duodenal/Pyloric Stent Market Growth, by Type, US, 2010 - 2015
  • Table 35: Colonic and Duodenal/Pyloric Stent Market, by Type, as a % of Total, US, 2009 - 2015
  • Table 36: Drivers of the Colonic and Duodenal/Pyloric Stent Market, US
  • Table 37: Limiters of the Colonic and Duodenal/Pyloric Stent Market, US
  • Table 38: Leading Competitors in the Colonic and Duodenal/Pyloric Stent Market, as a % of Total, US, 2009

6.0 BRONCHIAL AND TRACHEAL STENT MARKET

  • Figure 14: Bronchial and Tracheal Stent Market, by Material, US (US$), 2009 - 2015
  • Table 39: Features of Different Bronchial and Tracheal Stents, by Type, US
  • Table 40: Bronchial and Tracheal Stent Procedures, US, 2009 - 2015
  • Table 41: Bronchial and Tracheal Stent Market, by Material, US (US$), 2009 - 2015
  • Table42: Bronchial and Tracheal Stent Market Growth, by Material, US, 2010 - 2015
  • Table 43: Bronchial and Tracheal Stent Market, by Material, as a % of Total, US, 2009 - 2015
  • Table 44: Drivers of the Bronchial and Tracheal Stent Market, US
  • Table 45: Limiters of the Bronchial and Tracheal Stent Market, US
  • Table 46: Leading Competitors in the Bronchial and Tracheal Stent Market, by Material, as a % of Total, US, 2010

7.0 PROSTATIC STENT MARKET

  • Figure 15: Prostatic Stent Market, by Type, US (US$), 2009 - 2015
  • Table 47: Prostatic Stent Procedures, US, 2009 - 2015
  • Table 48: Prostatic Stent Market, by Type, US (US$), 2009 - 2015
  • Table 49: Prostatic Stent Market Growth, by Type, US, 2010 - 2015
  • Table 50: Prostatic Stent Market, by Type, as a % of Total, US, 2009 - 2015
  • Table 51: Drivers of the Prostatic Stent Market, US
  • Table 52: Limiters of the Prostatic Stent Market, US
  • Table 53: Leading Competitors in the Prostatic Stent Market, by Type, as a % of Total, US, 2010

APPENDIX A: MRG ACRONYMS AND INITIALISMS

  • MRG Acronyms and Initialisms

APPENDIX B: SUPPLEMENTAL FIGURES

  • Figure 16: Nonvascular Stent Market, by Material, US (US$), 2009 - 2015 (Detailed Format)
  • Figure 17: Ureteral Stent Market, US (US$), 2009 - 2015 (Detailed Format)
  • Figure 18: Biliary and Pancreatic Stent Procedures, by Technique, US, 2009 - 2015 (Detailed Format)
  • Figure 19: Esophageal Stent Market, by Type, as a % of Total, US, 2009 - 2015 (Detailed Format)
  • Figure 20: Colonic and Duodenal/Pyloric Stent Market Growth, by Type, US, 2010 - 2015 (Detailed Format)
  • Figure 21: Bronchial and Tracheal Stent Market, by Material, US (US$), 2009 - 2015 (Detailed Format)
  • Figure 22: Prostatic Stent Market, by Type, as a % of Total, 2010 and 2015 (Detailed Format)

Press Release

不能切除的結腸癌加速美國結腸、幽門、前列腺支架置放術 (STENT)

2011年08月22日

美國的結腸、十二指腸/幽門、前列腺支架置放術市場預計於2015年之前將倍增

Global Information, Inc.提交Millennium Research Group新的市場調查報告「US Markets for Nonvascular Stents 2011 (美國的非血管支架市場:2011年)」。

結腸是牽引十二指腸/幽門支架置放術成長的主因，乃因結腸癌不能切除的治療法，發生率雖然上升，然不能手術治療。對於支架置放術超過剖腹手術的優勢，醫生意識的廣泛高漲亦推動了需求。支架置放術具低侵襲性、高成功率、及併發症少等的優勢。容易配置、被覆自動擴張性金屬支架(SEMS (SEMS)等產品的技術創新亦對市場的成長有所貢獻。

美國的結腸、十二指腸/幽門支架置放術由Boston Scientific獨佔。Cook Medical的市佔率雖然很小，然最近被承認的進化型放出控制直腸•十二指腸支架置放系統產品正打算提高其地位。該產品的設計乃為降低穿孔和移動的風險。其他新進入的SEMS競爭企業有M.I. Tech和Taewoong Medical，兩家公司在他國都有複數的版本，預測最早2011年後半期這些裝置就能獲得食品藥物管理局的認可。

非血管支架置放術市場上亦有輸尿管支架置放、膽管及胰臟支架置放、食道支架置放、支氣管支架置放、氣管支架置放等。在美國有1億8,500萬美元規模的非血管支架置放術，今後5年將以年率5％弱的平均成長率緩慢成長。結腸、十二指腸/幽門、前列腺區塊，預計更加戲劇性擴大，2015年時平均年間收益各有15％以上的成長率。

本報告中有美國輸尿管、膽管及胰臟、食管、結腸、十二指腸/幽門、支氣管、氣管、前列腺的支架置放市場之促進因素和阻礙因素、競爭環境、以及處理的概要、件數、平均銷售價格和收益資訊等。
Back to Top